+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07519421

Different Laser Frequencies on Neuropathic Outcomes in Patients With Bells Palsy

Led by Kafrelsheikh University · Updated on 2026-04-09

80

Participants Needed

1

Research Sites

6 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This research aims to compare how different laser wavelengths 808 nm, 980 nm, and 1064 nm affect nerve healing in patients with Bells palsy, a condition causing facial paralysis and movement problems. By studying these laser treatments, researchers hope to improve clinical care, rehabilitation methods, and quality of life for people with this nerve disorder. Participants are randomly assigned to one of four groups a sham laser device group, a Low-Level Laser Therapy group, a gallium arsenide diode laser group, or a high-intensity laser treatment group. Each group receives 18 treatment sessions over six weeks, with three sessions each week. All participants also receive facial muscle massage and exercises to support nerve recovery. During the study, researchers will assess the facial nerve function using compound motor action potential tests at the start and after six weeks of treatment. Other assessments include facial disability scoring and monitoring of therapy sessions. The total study period includes the six-week treatment phase, with safety and progress tracked throughout.

CONDITIONS

Brief Title

Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 18 years and older
  • Diagnosed with unilateral Bell's palsy on either the right or left side
  • Both male and female participants
  • Facial disability index will be used for assessment before and after treatment
  • Patients with House-Brackmann scale levels II, III, IV, or V
Not Eligible

You will not qualify if you...

  • Patients with central nervous system pathology or facial sensory loss
  • Recurrence of facial palsy
  • Upper motor neuron facial nerve palsy
  • Children under 18 years
  • Bilateral facial nerve palsy
  • Severe hypertension (blood pressure over 200/120 mmHg)

Research Team

A

Ahmed Eid Lafi Aljohani, physical therapist

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here